Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major

Maria Ester Bernardo, Marco Zecca, Eugenia Piras, Adriana Vacca, Giovanna Giorgiani, Chiara Cugno, Giovanni Caocci, Patrizia Comoli, Angela Mastronuzzi, Pietro Merli, Giorgio La Nasa, Franco Locatelli

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The safety and efficacy of a preparation with treosulfan/thiotepa/ fludarabine were explored in 20 thalassaemia patients given allogeneic marrow transplantation. Seventeen patients were transplanted from unrelated donors after receiving anti-thymocyte globulin. The regimen was well tolerated. Two patients experienced secondary graft failure; one died of acute graft-versus-host disease. Cumulative incidence (95% confidence interval, CI) of transplantation-related mortality and graft failure was 5% (95% CI, 0-34%) and 11% (95% CI, 3-43%), respectively. Two-year probability of survival and thalassaemia-free survival was 95% (95% CI, 85-100%) and 85% (95% CI, 66-100%), respectively. This regimen might find elective application in patients at high risk of developing life-threatening complications.

Original languageEnglish
Pages (from-to)548-551
Number of pages4
JournalBritish Journal of Haematology
Volume143
Issue number4
DOIs
Publication statusPublished - Nov 2008
Externally publishedYes

Fingerprint

treosulfan
beta-Thalassemia
Hematopoietic Stem Cell Transplantation
Confidence Intervals
Thalassemia
Thiotepa
Transplants
Unrelated Donors
Antilymphocyte Serum
Survival
Homologous Transplantation
Graft vs Host Disease
Transplantation
Bone Marrow
Safety

Keywords

  • Conditioning regimen
  • Haematopoietic stem cell transplantation
  • Thalassaemia major
  • Toxicity
  • Treosulfan

ASJC Scopus subject areas

  • Hematology

Cite this

Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. / Bernardo, Maria Ester; Zecca, Marco; Piras, Eugenia; Vacca, Adriana; Giorgiani, Giovanna; Cugno, Chiara; Caocci, Giovanni; Comoli, Patrizia; Mastronuzzi, Angela; Merli, Pietro; La Nasa, Giorgio; Locatelli, Franco.

In: British Journal of Haematology, Vol. 143, No. 4, 11.2008, p. 548-551.

Research output: Contribution to journalArticle

Bernardo, ME, Zecca, M, Piras, E, Vacca, A, Giorgiani, G, Cugno, C, Caocci, G, Comoli, P, Mastronuzzi, A, Merli, P, La Nasa, G & Locatelli, F 2008, 'Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major', British Journal of Haematology, vol. 143, no. 4, pp. 548-551. https://doi.org/10.1111/j.1365-2141.2008.07385.x
Bernardo, Maria Ester ; Zecca, Marco ; Piras, Eugenia ; Vacca, Adriana ; Giorgiani, Giovanna ; Cugno, Chiara ; Caocci, Giovanni ; Comoli, Patrizia ; Mastronuzzi, Angela ; Merli, Pietro ; La Nasa, Giorgio ; Locatelli, Franco. / Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. In: British Journal of Haematology. 2008 ; Vol. 143, No. 4. pp. 548-551.
@article{60c1b4cc9bbf41f8aebed9c342e190bb,
title = "Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major",
abstract = "The safety and efficacy of a preparation with treosulfan/thiotepa/ fludarabine were explored in 20 thalassaemia patients given allogeneic marrow transplantation. Seventeen patients were transplanted from unrelated donors after receiving anti-thymocyte globulin. The regimen was well tolerated. Two patients experienced secondary graft failure; one died of acute graft-versus-host disease. Cumulative incidence (95{\%} confidence interval, CI) of transplantation-related mortality and graft failure was 5{\%} (95{\%} CI, 0-34{\%}) and 11{\%} (95{\%} CI, 3-43{\%}), respectively. Two-year probability of survival and thalassaemia-free survival was 95{\%} (95{\%} CI, 85-100{\%}) and 85{\%} (95{\%} CI, 66-100{\%}), respectively. This regimen might find elective application in patients at high risk of developing life-threatening complications.",
keywords = "Conditioning regimen, Haematopoietic stem cell transplantation, Thalassaemia major, Toxicity, Treosulfan",
author = "Bernardo, {Maria Ester} and Marco Zecca and Eugenia Piras and Adriana Vacca and Giovanna Giorgiani and Chiara Cugno and Giovanni Caocci and Patrizia Comoli and Angela Mastronuzzi and Pietro Merli and {La Nasa}, Giorgio and Franco Locatelli",
year = "2008",
month = "11",
doi = "10.1111/j.1365-2141.2008.07385.x",
language = "English",
volume = "143",
pages = "548--551",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major

AU - Bernardo, Maria Ester

AU - Zecca, Marco

AU - Piras, Eugenia

AU - Vacca, Adriana

AU - Giorgiani, Giovanna

AU - Cugno, Chiara

AU - Caocci, Giovanni

AU - Comoli, Patrizia

AU - Mastronuzzi, Angela

AU - Merli, Pietro

AU - La Nasa, Giorgio

AU - Locatelli, Franco

PY - 2008/11

Y1 - 2008/11

N2 - The safety and efficacy of a preparation with treosulfan/thiotepa/ fludarabine were explored in 20 thalassaemia patients given allogeneic marrow transplantation. Seventeen patients were transplanted from unrelated donors after receiving anti-thymocyte globulin. The regimen was well tolerated. Two patients experienced secondary graft failure; one died of acute graft-versus-host disease. Cumulative incidence (95% confidence interval, CI) of transplantation-related mortality and graft failure was 5% (95% CI, 0-34%) and 11% (95% CI, 3-43%), respectively. Two-year probability of survival and thalassaemia-free survival was 95% (95% CI, 85-100%) and 85% (95% CI, 66-100%), respectively. This regimen might find elective application in patients at high risk of developing life-threatening complications.

AB - The safety and efficacy of a preparation with treosulfan/thiotepa/ fludarabine were explored in 20 thalassaemia patients given allogeneic marrow transplantation. Seventeen patients were transplanted from unrelated donors after receiving anti-thymocyte globulin. The regimen was well tolerated. Two patients experienced secondary graft failure; one died of acute graft-versus-host disease. Cumulative incidence (95% confidence interval, CI) of transplantation-related mortality and graft failure was 5% (95% CI, 0-34%) and 11% (95% CI, 3-43%), respectively. Two-year probability of survival and thalassaemia-free survival was 95% (95% CI, 85-100%) and 85% (95% CI, 66-100%), respectively. This regimen might find elective application in patients at high risk of developing life-threatening complications.

KW - Conditioning regimen

KW - Haematopoietic stem cell transplantation

KW - Thalassaemia major

KW - Toxicity

KW - Treosulfan

UR - http://www.scopus.com/inward/record.url?scp=54849419695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54849419695&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2008.07385.x

DO - 10.1111/j.1365-2141.2008.07385.x

M3 - Article

VL - 143

SP - 548

EP - 551

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -